THE SERVER ENCOUNTERED AN INTERNAL ERROR OR MISCONFIGURATION AND WAS UNABLE TO COMPLETE YOUR REQUEST
Try refreshing your browser. If the problem persists, return to the homepage.
Non-Hodgkin’s Lymphoma (NHL)
RIABNI™ (rituximab-arrx) is indicated for the treatment of adult patients with:
Chronic Lymphocytic Leukemia (CLL)
RIABNI™, in combination with fludarabine and cyclophosphamide (FC), is indicated for the treatment of adult patients with previously untreated and previously treated CD20-positive CLL.
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA)
RIABNI™, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA).
Try refreshing your browser. If the problem persists, return to the homepage.